About Ona Therapeutics
Ona Therapeutics develops antibody-drug conjugates (ADCs) and antibody-based therapies. It focuses on identifying novel therapeutic targets by studying the molecular characteristics of refractory cancers. The company aims to provide new treatments for patients with advanced cancer who have limited options.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $86,600,000 · Series-B+
irbbarcelona.org
- Capital Raise
Raised $86,600,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $33,924,000 · Series-A
- Milestone
X account created (@OnaTherapeutics)
402 followers
- Milestone
Website domain registered
ona-therapeutics.com
- Milestone
Company founded
Barcelona, Spain
Investors & Backers
Funding History
Founders & Leadership
Joel Mairet
Director
Jutta Amersdorffer
Chief Medical Officer
Salvador Aznar Benitah
scientific co-founder
Valerie Vanhooren
Co-founder and Chief Executive Officer
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com